Danish pharmaceutical company Novo Nordisk, maker of the diabetes and weight-loss drugs Ozempic and Wegovy, became Europe's most valuable publicly listed company by market capitalization, at times exceeding the value of Denmark's entire economy. It has repeatedly traded that top spot with other European firms since.
Record no. MRB-2026-005890
Europe's Most Valuable Company
Reference Record – Not Certified
This record is compiled from publicly available sources for reference. It has not been examined or certified by The Book of World Records.